Checklists are very useful to ensure major issues are being addressed and the results are relevant to stakeholders, like payers, patients, and HTA bodies (as well as to make sure they meet pharma’s business objectives!). In an effort to begin creating a Checklist for Success for Late-Phase Research, Strategic Market Insights, LLC is conducting a very short survey to gather YOUR insights on what should be on a Checklist for Success for Phase 3, 4, and Observational Studies. Results will be disseminated in an October 20th Webinar and later in a December 11, 2014 virtual meeting on Real World Evidence: Stakeholder Perspectives in HE-Xpo. Take the short Survey and make your views known, here. (Source: Strategic Market Insight, LLC).
You are here: / / Phase III, IV and Observational Studies – What’s On Your Checklist For Success?